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Abstract
The influence of the autonomic nervous system (ANS) on triggering and perpetuation of atrial 
fibrillation (AF) is well established. Ganglionated plexi (GP) ablation achieves autonomic 
denervation by affecting both the parasympathetic and sympathetic components of the ANS. An 
anatomic approach for GP ablation at relevant atrial sites appears to be safe, and improves the 
results of PV isolation in patients with paroxysmal and persistent AF. GP ablation can be 
accomplished endocardially or epicardially, ie, during the maze procedure or thoracoscopic 
approaches. Further experience is needed to assess the clinical value of this promising 
technique.  
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Introduction
The influence of the autonomic nervous system (ANS) on the triggering and perpetuation of 
atrial fibrillation (AF) is well established. Variations of the autonomic tone have been 
associated with paroxysms of AF and both sympathetic and parasympathetic activation may be 
proarrhythmic by shortening of atrial refractoriness.[1-3] Vagal reflexes from clusters of 
autonomic ganglia, so-called ganglionated plexi (GP), at sites around the circumference of the 
left atrial-pulmonary vein (PV) junction (Figure 1), may induce and perpetuate AF through 
spatial heterogeneity of refractoriness.[1,4] In clinical practice, inadverted parasympathetic 
denervation has been proposed as a potential mechanism of circumferential or antral PV 
ablation for the treatment of atrial fibrillation.[5,6] Initial studies on partial vagal denervation 
via epicardial fat pad ablation indicated that such a dedicated approach may prevent AF,[7,8] 
although results have not been consistent.[9-11] Ablation of areas with prominent sympathetic 
innervation has also prevented sympathetic AF. The ligament of Marshall is a left atrial 
epicardial neuromuscular bundle, rich in sympathetic innervation, that has been associated with 
the genesis of atrial tachyarrhymias and AF.[12-15] Epicardial ablation of the ligament of 
Marshall in the canine can terminate spontaneous atrial activity and prevent AF,[13] whereas in 
the human epicardial (through the coronary sinus)[16] or endocardial [14,15] ablation at the 
insertion site of the Marshall bundle may terminate AF. We know now that selective 
parasympathetic or sympathetic denervation may not be feasible. Both sympathetic and 
parasympathetic elements reside in all four major left atrial ganglionated plexi,[16,17] and 
ablation lesions may unavoidably affect both components of the autonomic nervous system. 
The area around the ligament of Marshall that has been previously thought to represent an area 
of predominantly sympathetic innervation has been shown to contain parasympathertic fibers as 
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well.[18] Thus, although initial studies on GP ablation were characterized as attempts at 
specific parasympathetic denervation, this may not be true. Actually, ablation of atrial areas 
containing GP unavoidably results in autonomic denervation.
Figure 1. Anatomic position of the major GP targeted for catheter ablation. Presumed GP clusters are ablated 1-2 
cm outside the PV-LA junctions at the following sites: left superolateral area (superior left GP-SLGP), right 
superoanterior area  (anterior right GP-ARGP),  left inferoposterior area  (inferior left GP-ILGP), and  right 
inferoposterior area (inferior right GP-IRGP). Another GP (crux GP) the inferoposterior area between the ILGP 
and IRGP is not indicated. Reprinted from from Katritsis DG et al. Rapid pulmonary vein isolation combined with 
autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8:672-8. Copyright (2011), with 
permission   from   Elsevier.                                                                        
Techniques   of   GP   ablation                                                                          
In the electrophysiology laboratory and the operating theater, identification of major GP has been 
mainly accomplished through high-frequency stimulation (HFS) and induction of vagal responses 
in the atria.[19,20] HFS is delivered at 1,200 bpm (20 Hz) with a pulse width of 10 ms at 12-24 
V.[21] A predominant efferent vagal response is defined as induction of AV block (> 2 sec) and 
hypotension or prolongation of the R-R interval by >50% during AF, following a 5-second 
application of high-frequency stimulation. During these studies the anatomic locations of these 
plexi in the human have been well characterized. However, the method usually entails the 
discomfort of general anaesthesia, since conscious patients may not tolerate more than 15 V. 
Furthermore, we have recently shown that that anatomic ablation, ie targeting the areas known to 
host GP in the left atrium (Figure 1) without previous identification of GP, yields superior 
clinical results than HFS-identification and ablation of GP in patients with paroxysmal AF.[22]
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Clinical   Experience                                                                              
Ablation in the Electrophysiology Laboratory                                             
Isolated GP ablation has been employed for both paroxysmal and persistent AF with variable 
success. In paroxysmal AF, arrhythmia-free survival within the first year after the procedure 
ranged between 26 to 77%.[22-26] Success rates of <40% have been reported for persistent AF 
after a single procedure.[27] GP ablation in combination with pulmonary vein (PV) isolation has 
yielded better results than PV isolation alone with reported success rates up to 80%.[4,26,28-30] 
We have conducted the only randomized study that has compared the efficacy of PV isolation vs 
PV isolation+GP ablation in 67 patients with paroxysmal AF. Recurrence of arrhythmia was 
documented in 18 (54.5%) patients in the PV group 4.7 ± 1.0 months after ablation, and repeat 
PV isolation was performed in 7 (21.2%) of these patients 5.1 ± 1.1 months after the first 
procedure. Recurrence of arrhythmia was documented in 9 (26.5%) patients in the GP+PV group 
5.0 ± 1.3 months after ablation, and repeat ablation was performed in 6 (17.6%) of these patients 
4.3 ± 0.5 months after the first procedure. At the end of follow-up, 20 (60.6%) patients in the PV 
group and 29 (85.3%) patients in the GP+PV group remained arrhythmia-free (log rank test, P = 
0.019).[29]
Intraoperative   Ablation                                                                                    
Addition of GP ablation to the conventional Maze procedure has produced improved outcomes 
with success rates 83-93% over the following year.[31-33] Although this approach is interesting 
it is associated by the risks of open heart surgery and the Maze which nowadays is only 
considered in patients subjected to valve surgery.                                                                     
Thoracoscopic   Approaches                                                                                  
Thoracoscopic approaches combine PV isolation with selective GP ablation, with or without 
ligament of Marshall ablation or left atrial appendage amputation.[34-38] The reported success 
rates over one year follow-up range from 65 to 86%, and the procedure does not appear to have 
any associated mortality, with pleural effusion, pneumothorax, hemothorax, and phrenic nerve 
injury the reported complications so far.                                                                                   
Complications of GP ablation                                                                                               
Ablation-induced atrial or ventricular proarrhythmia has been reported with both endocardial and 
epicardial (thoracoscopic) approaches.[28,39-40] Anatomic GP modification appears to carry a 
higher risk of iatrogenic left atrial tachycardias than PV isolation. In our experience, anatomic or 
HFS-mediated GP ablation is complicated by atrial macroreentry in 2-10% of patients treated, but 
does not always require a repeat procedure, since these tachycardias may spontaneously resolve 
with time.[22,25,27,29]                                                                                               
The   Future                                                                                                    
GP ablation appears to be a safe and efficacious method to improve PV isolation in patients with 
AF, and has been used in the electrophysiology laboratory, and during the maze procedure or 
thoracoscopic approaches.[41] However experience is limited and mainly based in patients with 
paroxysmal AF. Furthermore, the long-term efficacy is not known, and this is particularly 
important since restoration of autonomic activity may occur as early as 4 weeks following 
ablation.[41] Controlled, randomized  studies and more  clinical  experience  are  needed  to 
accurately assess the clinical usefulness of this promising technique.                                     
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